NIH Reporter #RFA-AI-24-003

NIH NIAID Grant Opportunity for Multi-Omics Assay Development to Predict Radiation Organ Injuries

This opportunity from the National Institute of Allergy and Infectious Diseases (NIAID), part of NIH, seeks research proposals for developing multi-omics assays to predict late radiation organ injuries. - Government Buyer: - National Institutes of Health (NIH) - National Institute of Allergy and Infectious Diseases (NIAID) - Scope of Work: - Advanced development of multi-omics based assays for predicting radiation-induced organ injuries (DEARE-Watch project) - Focus on biomarker panel development for lung and kidney injury risk assessment - Includes software development and validation in animal and human models - Goal to achieve FDA qualification for biomarker panels - Products/Services Requested: - Research and development services (no specific products, part numbers, or quantities listed) - Unique Requirements: - Multi-omics assay development - Biomarker panel qualification and validation - Application in both animal and human biological models - Budget and Duration: - Total budget: $540,288 - Project duration: approximately five years - No specific OEMs or vendors are named in the notice.

Description

This is a research grant opportunity focused on developing biomarkers for radiation injury prediction. The project involves multi-omics assays, software development, and validation in animal models and humans. The goal is to develop FDA-qualified biomarker panels for lung and kidney injury risk assessment. The project duration is approximately 5 years with a budget of $540,288. The funding agency is the National Institute of Allergy and Infectious Diseases (NIAID), part of the NIH.

View original listing